Monitoring of systemic anticoagulation during cardiopulmonary bypass
- 31 March 1996
- journal article
- Published by Elsevier in The Annals of Thoracic Surgery
- Vol. 61 (3) , 781-782
- https://doi.org/10.1016/0003-4975(95)01181-1
Abstract
No abstract availableThis publication has 12 references indexed in Scilit:
- Warfarin pretreatment does not lead to increased bleeding tendency during cardiac surgeryJournal of Cardiothoracic and Vascular Anesthesia, 1995
- Effect of celite and kaolin on activated clotting time in the presence of aprotinin: Activated clotting time is reduced by binding of aprotinin to kaolinThe Journal of Thoracic and Cardiovascular Surgery, 1995
- Celite and Kaolin Produce Differing Activated Clotting Times during Cardiopulmonary Bypass under Aprotinin TherapyThe Thoracic and Cardiovascular Surgeon, 1994
- Alternative perioperative anticoagulation monitoring during cardiopulmonary bypass in aprotinin-treated patientsJournal of Cardiothoracic and Vascular Anesthesia, 1994
- The platelet function defect of cardiopulmonary bypass [see comments]Blood, 1993
- Influence of High-dose Aprotinin Treatment on Blood Loss and Coagulation Patterns in Patients Undergoing Myocardial RevascularizationAnesthesiology, 1990
- Alterations in coagulation and fibrinolysis associated with cardiopulmonary bypass during open heart surgeryJournal of Cardiothoracic Anesthesia, 1989
- Evaluation of Tests Used to Monitor Heparin Therapy during Extracorporeal CirculationAnesthesiology, 1975
- Heparin therapy during extracorporeal circulationThe Journal of Thoracic and Cardiovascular Surgery, 1975
- Heparin therapy during extracorporeal circulationThe Journal of Thoracic and Cardiovascular Surgery, 1975